Decentralized clinical trials (DCTs) facilitate conducting studies outside the physical boundaries of traditional clinical research facilities. They can extend the reach of clinical investigations to historically underserved populations while enabling incorporation of tools, such as digital health and telemedicine, for high-frequency remote monitoring of patients in real-world settings. DCTs require special attention to cybersecurity and data privacy protection laws and can be an efficient means of supporting a more patient-centered and inclusive clinical research enterprise.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据